2011年我院鲍曼不动杆菌感染的分布及耐药性研究

Clinical distribution of acinetobacter baumannii and drug resistance in 2011

目的:了解2011年本院鲍曼不动杆菌的临床分布及耐药性变迁,为合理应用抗菌药物提供依据。方法:采用回顾性研究,对鲍曼不动杆菌对常用的抗菌药物的耐药性状况进行分析。结果:鲍曼不动杆菌临床分布以ICU最多(占22.42%),其中奈替米星和阿米卡星的耐药率最低,其他抗菌药物耐药率均已大于40%,碳青霉烯类抗菌药物耐药率上升。结论:监测鲍曼不动杆菌的临床分布及对常用抗菌药物的耐药率,对指导临床合理选用抗菌药物和防治医院感染有重要意义。

Objective： To understand clinical distribution of acinetobacter banmannii and drug resistance in our hospita in 2011, and provide the basis for the rational use of antimicrobial drugs. Methods： A retrospective study of acinetobacter banmannii com- monly used antibacterial drug resistance situation analysis. Results： Acinetobacter clinical distributed to ICU dominant （22. 42% ）, netilmicin, amikacin lowest rate of other antimicrobial resistance rates of greater than 40% , the carbapenem class of anti- bacterial drug resistance rates rise. Conclusion ： Monitoring clinical distribution of acinetobacter banmannii and rate of resistance to commonly used antibiotics, rational use of antimicrobial drugs for clinical and prevention of hospital infections is important. Adipo- genesis, Differentiation.